Medical Isotopes Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Medical Isotopes market size was valued at USD 800 million in 2022 and is forecast to a readjusted size of USD 1020.7 million by 2029 with a CAGR of 3.5% during review period.

A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use. In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.

Many medical products today are sterilized by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilization. The disposable syringe is an example of a product sterilized by gamma rays. Because it is a 'cold' process radiation can be used to sterilize a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilization are installed in many countries. Smaller gamma irradiators, often utilizing Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilization by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilized by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.

North America is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 15% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990’s other governments began to view the isotope industry as a high-tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.

This report is a detailed and comprehensive analysis for global Medical Isotopes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Medical Isotopes market size and forecasts, in consumption value ($ Million), 2018-2029
Global Medical Isotopes market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Medical Isotopes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Medical Isotopes market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Isotopes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Medical Isotopes market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   NRG
   NTP Radioisotopes
   JSC Isotope
   ANSTO
   IRE
   Nordion
   Curium Pharma
   Cambridge Isotope Laboratories
   Eckert & Ziegler Strahlen
   Polatom
   Center of Molecular Research
   China National Nuclear Corporation
   Urenco
   LANL
   Shanghai Engineering Research Center
   IDB Holland
   NHTC
   Linde
   ORNL
   SI Science

   Stable Isotopes
   Radioisotopes

   Nuclear Therapy
   Equipment Radioactive Source
   Diagnosis

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the Medical Isotopes Market in 2025?

The medical isotopes market benefits from increasing demand for diagnostic imaging, cancer treatments, and advancements in nuclear medicine. Strong regulatory support and partnerships between hospitals, pharmaceutical companies, and research institutes also boost market growth. Additionally, the development of newer isotopes with improved efficacy and safety profiles strengthens the market’s position.

What weaknesses might affect the Medical Isotopes Market by 2025?

The high production costs of medical isotopes and the complex regulatory approvals required for new isotopes may limit the market’s expansion. There’s also a reliance on limited production facilities, which can result in supply shortages and disruptions. Furthermore, the handling and disposal of radioactive materials pose safety and environmental challenges.

What opportunities are expected for the Medical Isotopes Market by 2025?

Technological innovations in isotope production, along with the rising incidence of cancer and cardiovascular diseases, offer substantial growth opportunities. The expansion of nuclear medicine into emerging markets, where healthcare systems are rapidly evolving, will open new avenues for the industry. Additionally, there’s potential for the development of more targeted therapies, which can drive demand for specialized isotopes.

What threats could hinder the growth of the Medical Isotopes Market by 2025?

Regulatory hurdles and geopolitical factors affecting the supply chain are significant threats to the market. The risk of supply disruptions due to reliance on a few key producers or political tensions could impact the global availability of isotopes. Moreover, alternative diagnostic and treatment methods, such as molecular imaging or genetic therapies, could pose competitive challenges to the market.

What political factors could impact the Medical Isotopes Market by 2025?

Political stability and international cooperation are crucial for the smooth production and distribution of medical isotopes. Trade restrictions, regulations on radioactive materials, and international sanctions could disrupt supply chains. Additionally, government policies regarding healthcare funding and support for nuclear medicine research will play a significant role in market growth.

How do economic factors affect the Medical Isotopes Market in 2025?

The medical isotopes market is influenced by healthcare budgets and funding, particularly in developed countries where public healthcare spending is significant. Economic downturns could lead to reduced healthcare spending, affecting the adoption of expensive technologies like nuclear medicine. On the other hand, economic growth in emerging markets can lead to increased demand for advanced diagnostic and therapeutic technologies.

What social factors will influence the Medical Isotopes Market by 2025?

An aging population, particularly in developed countries, will drive demand for medical isotopes due to the increasing prevalence of age-related diseases like cancer. Rising awareness about the benefits of early diagnosis and personalized medicine will also boost the demand for isotopes in healthcare. However, public concerns about the safety of radioactive materials might impact market growth unless there is increased awareness and transparency.

What technological advancements are expected to shape the Medical Isotopes Market by 2025?

Advancements in radiopharmaceuticals, production technologies, and imaging techniques will significantly impact the medical isotopes market. Innovations in accelerator-based isotope production, as well as the development of new isotopes with better targeting and lower radiation exposure, will enhance market growth. The integration of artificial intelligence (AI) in diagnostic imaging and treatment planning is another promising factor.

What environmental factors affect the Medical Isotopes Market in 2025?

Environmental concerns related to the production, transportation, and disposal of radioactive materials can pose challenges. Regulatory pressure for sustainable and safe practices will increase, requiring companies to invest in more environmentally friendly technologies. The development of isotopes with less environmental impact and better safety measures will be essential in overcoming these challenges.

What legal factors are expected to influence the Medical Isotopes Market by 2025?

The medical isotopes market is subject to stringent regulations regarding the handling, transport, and disposal of radioactive materials. Legal frameworks surrounding patent rights for new isotopes, licensing for production facilities, and safety standards will continue to play a major role. Changes in regulations, especially related to healthcare and nuclear safety, could either facilitate or hinder market growth.

Who are the suppliers in the Medical Isotopes Market by 2025?

Suppliers include nuclear reactors, cyclotron facilities, and specialized manufacturers that produce the raw materials required for isotopes. These also include medical isotope producers like pharmaceutical companies and research organizations that focus on the development and supply of radiopharmaceuticals. Additionally, equipment manufacturers for diagnostic imaging and radiation therapy contribute to the supply chain.

What inputs are needed in the Medical Isotopes Market in 2025?

The primary inputs include uranium or other raw materials for isotope production, advanced cyclotron equipment, skilled labor for production and research, and technological resources for maintaining quality standards. Other inputs include regulatory compliance documents, production facilities, and transport logistics for handling radioactive materials safely.

What processes are involved in the Medical Isotopes Market by 2025?

The key processes involve the production of medical isotopes through nuclear reactors or cyclotrons, followed by the radiolabeling of compounds for medical use. Quality control processes ensure isotopes meet safety and efficacy standards. Distribution logistics, including safe transportation, regulatory approvals, and timely delivery to healthcare providers and research institutions, are critical processes for the market.

Who are the customers in the Medical Isotopes Market in 2025?

The primary customers include hospitals, oncology centers, diagnostic imaging clinics, research institutions, and pharmaceutical companies. Additionally, governmental healthcare organizations, medical professionals, and private healthcare providers rely on medical isotopes for cancer diagnosis and treatment, as well as for other diagnostic procedures.

What are the outputs of the Medical Isotopes Market by 2025?

The outputs include a range of radiopharmaceuticals used for diagnostic imaging, cancer treatment, and other nuclear medicine applications. These isotopes enable non-invasive diagnostic procedures like PET scans and targeted radiation therapy. The market will also see the development of specialized isotopes for personalized treatments, improving patient outcomes.

How strong is the threat of new entrants in the Medical Isotopes Market by 2025?

The threat of new entrants is relatively low due to the high barriers to entry, including the need for specialized facilities (such as nuclear reactors and cyclotrons), significant capital investment, and complex regulatory approvals. The market is also highly specialized, requiring expertise in nuclear technology and radiopharmaceuticals, which limits the potential for new competitors to quickly enter and establish a foothold.

How intense is the bargaining power of suppliers in the Medical Isotopes Market by 2025?

The bargaining power of suppliers is moderate to high, as the production of medical isotopes depends on a limited number of specialized suppliers. There are only a few key players who can provide the necessary raw materials, such as uranium, and the technology required to produce isotopes. This makes suppliers crucial to the industry, although the growing adoption of alternative production methods could slightly reduce their power.

How strong is the bargaining power of buyers in the Medical Isotopes Market by 2025?

The bargaining power of buyers is moderate. While there is significant demand for medical isotopes, the specialized nature of the product means that customers (hospitals, clinics, and research organizations) do not have many alternatives in terms of quality and reliability. However, as the market for medical isotopes expands, buyers may gain more leverage, particularly with emerging alternatives like synthetic isotopes or AI-powered diagnostics.

How intense is the threat of substitutes in the Medical Isotopes Market by 2025?

The threat of substitutes is low, as there are few viable alternatives to medical isotopes for certain diagnostic and therapeutic applications, particularly in cancer treatment and imaging. While advancements in molecular imaging and genetic therapies may offer alternatives in some cases, medical isotopes remain the gold standard for specific medical conditions, which limits the potential for substitute products to replace them.

How competitive is the Medical Isotopes Market by 2025?

The medical isotopes market is moderately competitive. A small number of large companies dominate the production of isotopes, but there is still room for innovation, especially with new isotopes and production techniques. The market is likely to see increasing competition from both established players seeking to expand their portfolios and new entrants focusing on niche applications, such as targeted therapies or novel imaging solutions.

What are the key suppliers in the upstream of the Medical Isotopes Market by 2025?

Key suppliers in the upstream include nuclear reactors, cyclotron manufacturers, and specialized raw material providers such as uranium, molybdenum, and other isotopic elements. Additionally, technology suppliers that provide advanced production systems for radiopharmaceuticals, as well as companies involved in the research and development of new isotopes, play a crucial role.

What raw materials are critical in the upstream of the Medical Isotopes Market by 2025?

Critical raw materials include uranium for reactor-based isotope production, molybdenum-99 for the production of technetium-99m (a widely used isotope in diagnostics), and other rare elements needed for various isotopes. These materials must meet strict safety and regulatory standards, which adds complexity to their supply chain.

What technologies are involved in the upstream of the Medical Isotopes Market by 2025?

Technologies involved include cyclotron-based production for short-lived isotopes, nuclear reactors for longer-lived isotopes, and purification processes that ensure isotopes meet medical safety standards. Advances in automation and precision manufacturing technologies for isotope production are also becoming more important to ensure efficiency and scalability.

What are the key challenges faced by upstream players in the Medical Isotopes Market by 2025?

Key challenges include the high capital investment required for production facilities, the complexity of adhering to stringent regulatory requirements, and the need for continuous innovation to meet growing demand. Additionally, managing supply chain disruptions, such as political instability or raw material shortages, poses a significant risk for upstream players.

How do regulations impact the upstream of the Medical Isotopes Market by 2025?

Regulations play a pivotal role in ensuring the safety and efficacy of medical isotopes. Stringent regulatory frameworks govern the production, handling, and transportation of radioactive materials, which increases compliance costs and delays in bringing new isotopes to market. Additionally, regulatory approval for new production methods and facilities can be time-consuming and costly, influencing upstream operations.

What are the key players in the midstream of the Medical Isotopes Market by 2025?

Key players in the midstream include companies involved in the processing, distribution, and logistics of medical isotopes. These include specialized radiopharmaceutical manufacturers, distributors, and logistics providers who manage the transportation and safe handling of isotopes to healthcare facilities, hospitals, and diagnostic centers.

What processes are involved in the midstream of the Medical Isotopes Market by 2025?

The midstream processes involve the preparation and packaging of isotopes into radiopharmaceuticals, quality control testing, and regulatory compliance checks to ensure that isotopes meet medical standards. Additionally, logistics operations focus on the safe and timely delivery of isotopes to various healthcare providers, including transport regulations for handling radioactive materials.

What challenges are faced in the midstream of the Medical Isotopes Market by 2025?

Challenges include maintaining the stability and safety of isotopes during transportation, as many have a short half-life. There is also a risk of supply chain disruptions due to regulatory hurdles, global transport restrictions, and the complexity of managing multiple distribution channels. Furthermore, balancing demand fluctuations and ensuring timely delivery to healthcare providers can be difficult, especially in regions with limited infrastructure.

How does regulatory compliance impact the midstream of the Medical Isotopes Market by 2025?

Regulatory compliance is crucial in the midstream, as strict guidelines govern the handling, storage, and transportation of radioactive materials. Companies must ensure that they adhere to international and local regulations to prevent safety hazards and legal issues. This adds layers of complexity to operations, as frequent inspections, certifications, and documentation are required to ensure the safe distribution of isotopes.

How do technological advancements impact the midstream of the Medical Isotopes Market by 2025?

Technological advancements, such as improved packaging and tracking systems, are enhancing the efficiency and safety of isotope transportation. Automation in the production of radiopharmaceuticals and the use of AI in logistics optimization are also expected to streamline midstream operations. These innovations improve inventory management, reduce human error, and increase the speed at which isotopes reach end-users.

Who are the key stakeholders in the downstream of the Medical Isotopes Market by 2025?

Key stakeholders in the downstream include hospitals, diagnostic imaging centers, oncology clinics, and research institutions that utilize medical isotopes for diagnostics and treatments. Additionally, pharmaceutical companies that develop radiopharmaceuticals and healthcare professionals such as radiologists and oncologists play a crucial role in delivering medical isotope-based therapies and diagnostics.

What processes are involved in the downstream of the Medical Isotopes Market by 2025?

Downstream processes include the administration of radiopharmaceuticals to patients for diagnostic imaging (e.g., PET scans) or therapeutic applications (e.g., radiation therapy). This involves healthcare providers carefully managing patient care, interpreting diagnostic results, and applying personalized treatments. Ongoing patient monitoring and follow-up care after isotope-based treatments are also part of the downstream processes.

What are the challenges faced in the downstream of the Medical Isotopes Market by 2025?

Challenges in the downstream include the high cost of medical isotopes and radiopharmaceuticals, which can limit access to advanced treatments, particularly in resource-constrained settings. Additionally, the short half-life of many isotopes requires timely administration and careful logistical coordination. Healthcare providers also face the challenge of ensuring patient safety, given the potential risks of radiation exposure.

How does patient demand impact the downstream of the Medical Isotopes Market by 2025?

As the prevalence of conditions like cancer and cardiovascular diseases rises, there is an increasing demand for isotope-based diagnostics and treatments. The growing aging population and a higher focus on early detection and personalized medicine further drive this demand. This increased need for isotopes may create pressures on healthcare providers to manage patient volumes and treatment schedules efficiently.

How do technological advancements influence the downstream of the Medical Isotopes Market by 2025?

Technological advancements in imaging techniques, radiation therapy, and isotope-based treatments will enhance the effectiveness and precision of medical isotope applications. Innovations like targeted radiotherapy, personalized treatments, and improved diagnostic methods will provide better outcomes for patients. Additionally, AI and machine learning are expected to improve the interpretation of imaging data and optimize treatment protocols, making medical isotope use more efficient and accessible.

Chapter 1, to describe Medical Isotopes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Medical Isotopes, with revenue, gross margin and global market share of Medical Isotopes from 2018 to 2023.
Chapter 3, the Medical Isotopes competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Medical Isotopes market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Medical Isotopes.
Chapter 13, to describe Medical Isotopes research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Medical Isotopes
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Medical Isotopes by Type
       1.3.1 Overview: Global Medical Isotopes Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Medical Isotopes Consumption Value Market Share by Type in 2022
       1.3.3 Stable Isotopes
       1.3.4 Radioisotopes
   1.4 Global Medical Isotopes Market by Application
       1.4.1 Overview: Global Medical Isotopes Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Nuclear Therapy
       1.4.3 Equipment Radioactive Source
       1.4.4 Diagnosis
   1.5 Global Medical Isotopes Market Size & Forecast
   1.6 Global Medical Isotopes Market Size and Forecast by Region
       1.6.1 Global Medical Isotopes Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Medical Isotopes Market Size by Region, (2018-2029)
       1.6.3 North America Medical Isotopes Market Size and Prospect (2018-2029)
       1.6.4 Europe Medical Isotopes Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Medical Isotopes Market Size and Prospect (2018-2029)
       1.6.6 South America Medical Isotopes Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Medical Isotopes Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 NRG
       2.1.1 NRG Details
       2.1.2 NRG Major Business
       2.1.3 NRG Medical Isotopes Product and Solutions
       2.1.4 NRG Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 NRG Recent Developments and Future Plans
   2.2 NTP Radioisotopes
       2.2.1 NTP Radioisotopes Details
       2.2.2 NTP Radioisotopes Major Business
       2.2.3 NTP Radioisotopes Medical Isotopes Product and Solutions
       2.2.4 NTP Radioisotopes Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 NTP Radioisotopes Recent Developments and Future Plans
   2.3 JSC Isotope
       2.3.1 JSC Isotope Details
       2.3.2 JSC Isotope Major Business
       2.3.3 JSC Isotope Medical Isotopes Product and Solutions
       2.3.4 JSC Isotope Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 JSC Isotope Recent Developments and Future Plans
   2.4 ANSTO
       2.4.1 ANSTO Details
       2.4.2 ANSTO Major Business
       2.4.3 ANSTO Medical Isotopes Product and Solutions
       2.4.4 ANSTO Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 ANSTO Recent Developments and Future Plans
   2.5 IRE
       2.5.1 IRE Details
       2.5.2 IRE Major Business
       2.5.3 IRE Medical Isotopes Product and Solutions
       2.5.4 IRE Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 IRE Recent Developments and Future Plans
   2.6 Nordion
       2.6.1 Nordion Details
       2.6.2 Nordion Major Business
       2.6.3 Nordion Medical Isotopes Product and Solutions
       2.6.4 Nordion Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Nordion Recent Developments and Future Plans
   2.7 Curium Pharma
       2.7.1 Curium Pharma Details
       2.7.2 Curium Pharma Major Business
       2.7.3 Curium Pharma Medical Isotopes Product and Solutions
       2.7.4 Curium Pharma Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Curium Pharma Recent Developments and Future Plans
   2.8 Cambridge Isotope Laboratories
       2.8.1 Cambridge Isotope Laboratories Details
       2.8.2 Cambridge Isotope Laboratories Major Business
       2.8.3 Cambridge Isotope Laboratories Medical Isotopes Product and Solutions
       2.8.4 Cambridge Isotope Laboratories Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Cambridge Isotope Laboratories Recent Developments and Future Plans
   2.9 Eckert & Ziegler Strahlen
       2.9.1 Eckert & Ziegler Strahlen Details
       2.9.2 Eckert & Ziegler Strahlen Major Business
       2.9.3 Eckert & Ziegler Strahlen Medical Isotopes Product and Solutions
       2.9.4 Eckert & Ziegler Strahlen Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Eckert & Ziegler Strahlen Recent Developments and Future Plans
   2.10 Polatom 
       2.10.1 Polatom Details
       2.10.2 Polatom Major Business
       2.10.3 Polatom Medical Isotopes Product and Solutions
       2.10.4 Polatom Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Polatom Recent Developments and Future Plans
   2.11 Center of Molecular Research
       2.11.1 Center of Molecular Research Details
       2.11.2 Center of Molecular Research Major Business
       2.11.3 Center of Molecular Research Medical Isotopes Product and Solutions
       2.11.4 Center of Molecular Research Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Center of Molecular Research Recent Developments and Future Plans
   2.12 China National Nuclear Corporation
       2.12.1 China National Nuclear Corporation Details
       2.12.2 China National Nuclear Corporation Major Business
       2.12.3 China National Nuclear Corporation Medical Isotopes Product and Solutions
       2.12.4 China National Nuclear Corporation Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 China National Nuclear Corporation Recent Developments and Future Plans
   2.13 Urenco
       2.13.1 Urenco Details
       2.13.2 Urenco Major Business
       2.13.3 Urenco Medical Isotopes Product and Solutions
       2.13.4 Urenco Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 Urenco Recent Developments and Future Plans
   2.14 LANL
       2.14.1 LANL Details
       2.14.2 LANL Major Business
       2.14.3 LANL Medical Isotopes Product and Solutions
       2.14.4 LANL Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 LANL Recent Developments and Future Plans
   2.15 Shanghai Engineering Research Center
       2.15.1 Shanghai Engineering Research Center Details
       2.15.2 Shanghai Engineering Research Center Major Business
       2.15.3 Shanghai Engineering Research Center Medical Isotopes Product and Solutions
       2.15.4 Shanghai Engineering Research Center Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.15.5 Shanghai Engineering Research Center Recent Developments and Future Plans
   2.16 IDB Holland
       2.16.1 IDB Holland Details
       2.16.2 IDB Holland Major Business
       2.16.3 IDB Holland Medical Isotopes Product and Solutions
       2.16.4 IDB Holland Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.16.5 IDB Holland Recent Developments and Future Plans
   2.17 NHTC
       2.17.1 NHTC Details
       2.17.2 NHTC Major Business
       2.17.3 NHTC Medical Isotopes Product and Solutions
       2.17.4 NHTC Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.17.5 NHTC Recent Developments and Future Plans
   2.18 Linde
       2.18.1 Linde Details
       2.18.2 Linde Major Business
       2.18.3 Linde Medical Isotopes Product and Solutions
       2.18.4 Linde Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.18.5 Linde Recent Developments and Future Plans
   2.19 ORNL
       2.19.1 ORNL Details
       2.19.2 ORNL Major Business
       2.19.3 ORNL Medical Isotopes Product and Solutions
       2.19.4 ORNL Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.19.5 ORNL Recent Developments and Future Plans
   2.20 SI Science
       2.20.1 SI Science Details
       2.20.2 SI Science Major Business
       2.20.3 SI Science Medical Isotopes Product and Solutions
       2.20.4 SI Science Medical Isotopes Revenue, Gross Margin and Market Share (2018-2023)
       2.20.5 SI Science Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Medical Isotopes Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Medical Isotopes by Company Revenue
       3.2.2 Top 3 Medical Isotopes Players Market Share in 2022
       3.2.3 Top 6 Medical Isotopes Players Market Share in 2022
   3.3 Medical Isotopes Market: Overall Company Footprint Analysis
       3.3.1 Medical Isotopes Market: Region Footprint
       3.3.2 Medical Isotopes Market: Company Product Type Footprint
       3.3.3 Medical Isotopes Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Medical Isotopes Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Medical Isotopes Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Medical Isotopes Consumption Value Market Share by Application (2018-2023)
   5.2 Global Medical Isotopes Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Medical Isotopes Consumption Value by Type (2018-2029)
   6.2 North America Medical Isotopes Consumption Value by Application (2018-2029)
   6.3 North America Medical Isotopes Market Size by Country
       6.3.1 North America Medical Isotopes Consumption Value by Country (2018-2029)
       6.3.2 United States Medical Isotopes Market Size and Forecast (2018-2029)
       6.3.3 Canada Medical Isotopes Market Size and Forecast (2018-2029)
       6.3.4 Mexico Medical Isotopes Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Medical Isotopes Consumption Value by Type (2018-2029)
   7.2 Europe Medical Isotopes Consumption Value by Application (2018-2029)
   7.3 Europe Medical Isotopes Market Size by Country
       7.3.1 Europe Medical Isotopes Consumption Value by Country (2018-2029)
       7.3.2 Germany Medical Isotopes Market Size and Forecast (2018-2029)
       7.3.3 France Medical Isotopes Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Medical Isotopes Market Size and Forecast (2018-2029)
       7.3.5 Russia Medical Isotopes Market Size and Forecast (2018-2029)
       7.3.6 Italy Medical Isotopes Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Medical Isotopes Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Medical Isotopes Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Medical Isotopes Market Size by Region
       8.3.1 Asia-Pacific Medical Isotopes Consumption Value by Region (2018-2029)
       8.3.2 China Medical Isotopes Market Size and Forecast (2018-2029)
       8.3.3 Japan Medical Isotopes Market Size and Forecast (2018-2029)
       8.3.4 South Korea Medical Isotopes Market Size and Forecast (2018-2029)
       8.3.5 India Medical Isotopes Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Medical Isotopes Market Size and Forecast (2018-2029)
       8.3.7 Australia Medical Isotopes Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Medical Isotopes Consumption Value by Type (2018-2029)
   9.2 South America Medical Isotopes Consumption Value by Application (2018-2029)
   9.3 South America Medical Isotopes Market Size by Country
       9.3.1 South America Medical Isotopes Consumption Value by Country (2018-2029)
       9.3.2 Brazil Medical Isotopes Market Size and Forecast (2018-2029)
       9.3.3 Argentina Medical Isotopes Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Medical Isotopes Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Medical Isotopes Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Medical Isotopes Market Size by Country
       10.3.1 Middle East & Africa Medical Isotopes Consumption Value by Country (2018-2029)
       10.3.2 Turkey Medical Isotopes Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Medical Isotopes Market Size and Forecast (2018-2029)
       10.3.4 UAE Medical Isotopes Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Medical Isotopes Market Drivers
   11.2 Medical Isotopes Market Restraints
   11.3 Medical Isotopes Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Medical Isotopes Industry Chain
   12.2 Medical Isotopes Upstream Analysis
   12.3 Medical Isotopes Midstream Analysis
   12.4 Medical Isotopes Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Medical Isotopes Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Medical Isotopes Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Medical Isotopes Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Medical Isotopes Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. NRG Company Information, Head Office, and Major Competitors
   Table 6. NRG Major Business
   Table 7. NRG Medical Isotopes Product and Solutions
   Table 8. NRG Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. NRG Recent Developments and Future Plans
   Table 10. NTP Radioisotopes Company Information, Head Office, and Major Competitors
   Table 11. NTP Radioisotopes Major Business
   Table 12. NTP Radioisotopes Medical Isotopes Product and Solutions
   Table 13. NTP Radioisotopes Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. NTP Radioisotopes Recent Developments and Future Plans
   Table 15. JSC Isotope Company Information, Head Office, and Major Competitors
   Table 16. JSC Isotope Major Business
   Table 17. JSC Isotope Medical Isotopes Product and Solutions
   Table 18. JSC Isotope Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. JSC Isotope Recent Developments and Future Plans
   Table 20. ANSTO Company Information, Head Office, and Major Competitors
   Table 21. ANSTO Major Business
   Table 22. ANSTO Medical Isotopes Product and Solutions
   Table 23. ANSTO Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. ANSTO Recent Developments and Future Plans
   Table 25. IRE Company Information, Head Office, and Major Competitors
   Table 26. IRE Major Business
   Table 27. IRE Medical Isotopes Product and Solutions
   Table 28. IRE Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. IRE Recent Developments and Future Plans
   Table 30. Nordion Company Information, Head Office, and Major Competitors
   Table 31. Nordion Major Business
   Table 32. Nordion Medical Isotopes Product and Solutions
   Table 33. Nordion Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Nordion Recent Developments and Future Plans
   Table 35. Curium Pharma Company Information, Head Office, and Major Competitors
   Table 36. Curium Pharma Major Business
   Table 37. Curium Pharma Medical Isotopes Product and Solutions
   Table 38. Curium Pharma Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Curium Pharma Recent Developments and Future Plans
   Table 40. Cambridge Isotope Laboratories Company Information, Head Office, and Major Competitors
   Table 41. Cambridge Isotope Laboratories Major Business
   Table 42. Cambridge Isotope Laboratories Medical Isotopes Product and Solutions
   Table 43. Cambridge Isotope Laboratories Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Cambridge Isotope Laboratories Recent Developments and Future Plans
   Table 45. Eckert & Ziegler Strahlen Company Information, Head Office, and Major Competitors
   Table 46. Eckert & Ziegler Strahlen Major Business
   Table 47. Eckert & Ziegler Strahlen Medical Isotopes Product and Solutions
   Table 48. Eckert & Ziegler Strahlen Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. Eckert & Ziegler Strahlen Recent Developments and Future Plans
   Table 50. Polatom Company Information, Head Office, and Major Competitors
   Table 51. Polatom Major Business
   Table 52. Polatom Medical Isotopes Product and Solutions
   Table 53. Polatom Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. Polatom Recent Developments and Future Plans
   Table 55. Center of Molecular Research Company Information, Head Office, and Major Competitors
   Table 56. Center of Molecular Research Major Business
   Table 57. Center of Molecular Research Medical Isotopes Product and Solutions
   Table 58. Center of Molecular Research Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 59. Center of Molecular Research Recent Developments and Future Plans
   Table 60. China National Nuclear Corporation Company Information, Head Office, and Major Competitors
   Table 61. China National Nuclear Corporation Major Business
   Table 62. China National Nuclear Corporation Medical Isotopes Product and Solutions
   Table 63. China National Nuclear Corporation Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 64. China National Nuclear Corporation Recent Developments and Future Plans
   Table 65. Urenco Company Information, Head Office, and Major Competitors
   Table 66. Urenco Major Business
   Table 67. Urenco Medical Isotopes Product and Solutions
   Table 68. Urenco Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 69. Urenco Recent Developments and Future Plans
   Table 70. LANL Company Information, Head Office, and Major Competitors
   Table 71. LANL Major Business
   Table 72. LANL Medical Isotopes Product and Solutions
   Table 73. LANL Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 74. LANL Recent Developments and Future Plans
   Table 75. Shanghai Engineering Research Center Company Information, Head Office, and Major Competitors
   Table 76. Shanghai Engineering Research Center Major Business
   Table 77. Shanghai Engineering Research Center Medical Isotopes Product and Solutions
   Table 78. Shanghai Engineering Research Center Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 79. Shanghai Engineering Research Center Recent Developments and Future Plans
   Table 80. IDB Holland Company Information, Head Office, and Major Competitors
   Table 81. IDB Holland Major Business
   Table 82. IDB Holland Medical Isotopes Product and Solutions
   Table 83. IDB Holland Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 84. IDB Holland Recent Developments and Future Plans
   Table 85. NHTC Company Information, Head Office, and Major Competitors
   Table 86. NHTC Major Business
   Table 87. NHTC Medical Isotopes Product and Solutions
   Table 88. NHTC Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 89. NHTC Recent Developments and Future Plans
   Table 90. Linde Company Information, Head Office, and Major Competitors
   Table 91. Linde Major Business
   Table 92. Linde Medical Isotopes Product and Solutions
   Table 93. Linde Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 94. Linde Recent Developments and Future Plans
   Table 95. ORNL Company Information, Head Office, and Major Competitors
   Table 96. ORNL Major Business
   Table 97. ORNL Medical Isotopes Product and Solutions
   Table 98. ORNL Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 99. ORNL Recent Developments and Future Plans
   Table 100. SI Science Company Information, Head Office, and Major Competitors
   Table 101. SI Science Major Business
   Table 102. SI Science Medical Isotopes Product and Solutions
   Table 103. SI Science Medical Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 104. SI Science Recent Developments and Future Plans
   Table 105. Global Medical Isotopes Revenue (USD Million) by Players (2018-2023)
   Table 106. Global Medical Isotopes Revenue Share by Players (2018-2023)
   Table 107. Breakdown of Medical Isotopes by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 108. Market Position of Players in Medical Isotopes, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 109. Head Office of Key Medical Isotopes Players
   Table 110. Medical Isotopes Market: Company Product Type Footprint
   Table 111. Medical Isotopes Market: Company Product Application Footprint
   Table 112. Medical Isotopes New Market Entrants and Barriers to Market Entry
   Table 113. Medical Isotopes Mergers, Acquisition, Agreements, and Collaborations
   Table 114. Global Medical Isotopes Consumption Value (USD Million) by Type (2018-2023)
   Table 115. Global Medical Isotopes Consumption Value Share by Type (2018-2023)
   Table 116. Global Medical Isotopes Consumption Value Forecast by Type (2024-2029)
   Table 117. Global Medical Isotopes Consumption Value by Application (2018-2023)
   Table 118. Global Medical Isotopes Consumption Value Forecast by Application (2024-2029)
   Table 119. North America Medical Isotopes Consumption Value by Type (2018-2023) & (USD Million)
   Table 120. North America Medical Isotopes Consumption Value by Type (2024-2029) & (USD Million)
   Table 121. North America Medical Isotopes Consumption Value by Application (2018-2023) & (USD Million)
   Table 122. North America Medical Isotopes Consumption Value by Application (2024-2029) & (USD Million)
   Table 123. North America Medical Isotopes Consumption Value by Country (2018-2023) & (USD Million)
   Table 124. North America Medical Isotopes Consumption Value by Country (2024-2029) & (USD Million)
   Table 125. Europe Medical Isotopes Consumption Value by Type (2018-2023) & (USD Million)
   Table 126. Europe Medical Isotopes Consumption Value by Type (2024-2029) & (USD Million)
   Table 127. Europe Medical Isotopes Consumption Value by Application (2018-2023) & (USD Million)
   Table 128. Europe Medical Isotopes Consumption Value by Application (2024-2029) & (USD Million)
   Table 129. Europe Medical Isotopes Consumption Value by Country (2018-2023) & (USD Million)
   Table 130. Europe Medical Isotopes Consumption Value by Country (2024-2029) & (USD Million)
   Table 131. Asia-Pacific Medical Isotopes Consumption Value by Type (2018-2023) & (USD Million)
   Table 132. Asia-Pacific Medical Isotopes Consumption Value by Type (2024-2029) & (USD Million)
   Table 133. Asia-Pacific Medical Isotopes Consumption Value by Application (2018-2023) & (USD Million)
   Table 134. Asia-Pacific Medical Isotopes Consumption Value by Application (2024-2029) & (USD Million)
   Table 135. Asia-Pacific Medical Isotopes Consumption Value by Region (2018-2023) & (USD Million)
   Table 136. Asia-Pacific Medical Isotopes Consumption Value by Region (2024-2029) & (USD Million)
   Table 137. South America Medical Isotopes Consumption Value by Type (2018-2023) & (USD Million)
   Table 138. South America Medical Isotopes Consumption Value by Type (2024-2029) & (USD Million)
   Table 139. South America Medical Isotopes Consumption Value by Application (2018-2023) & (USD Million)
   Table 140. South America Medical Isotopes Consumption Value by Application (2024-2029) & (USD Million)
   Table 141. South America Medical Isotopes Consumption Value by Country (2018-2023) & (USD Million)
   Table 142. South America Medical Isotopes Consumption Value by Country (2024-2029) & (USD Million)
   Table 143. Middle East & Africa Medical Isotopes Consumption Value by Type (2018-2023) & (USD Million)
   Table 144. Middle East & Africa Medical Isotopes Consumption Value by Type (2024-2029) & (USD Million)
   Table 145. Middle East & Africa Medical Isotopes Consumption Value by Application (2018-2023) & (USD Million)
   Table 146. Middle East & Africa Medical Isotopes Consumption Value by Application (2024-2029) & (USD Million)
   Table 147. Middle East & Africa Medical Isotopes Consumption Value by Country (2018-2023) & (USD Million)
   Table 148. Middle East & Africa Medical Isotopes Consumption Value by Country (2024-2029) & (USD Million)
   Table 149. Medical Isotopes Raw Material
   Table 150. Key Suppliers of Medical Isotopes Raw Materials

List of Figures

   Figure 1. Medical Isotopes Picture
   Figure 2. Global Medical Isotopes Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Medical Isotopes Consumption Value Market Share by Type in 2022
   Figure 4. Stable Isotopes
   Figure 5. Radioisotopes
   Figure 6. Global Medical Isotopes Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 7. Medical Isotopes Consumption Value Market Share by Application in 2022
   Figure 8. Nuclear Therapy Picture
   Figure 9. Equipment Radioactive Source Picture
   Figure 10. Diagnosis Picture
   Figure 11. Global Medical Isotopes Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 12. Global Medical Isotopes Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 13. Global Market Medical Isotopes Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 14. Global Medical Isotopes Consumption Value Market Share by Region (2018-2029)
   Figure 15. Global Medical Isotopes Consumption Value Market Share by Region in 2022
   Figure 16. North America Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 17. Europe Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 18. Asia-Pacific Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 19. South America Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 20. Middle East and Africa Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 21. Global Medical Isotopes Revenue Share by Players in 2022
   Figure 22. Medical Isotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 23. Global Top 3 Players Medical Isotopes Market Share in 2022
   Figure 24. Global Top 6 Players Medical Isotopes Market Share in 2022
   Figure 25. Global Medical Isotopes Consumption Value Share by Type (2018-2023)
   Figure 26. Global Medical Isotopes Market Share Forecast by Type (2024-2029)
   Figure 27. Global Medical Isotopes Consumption Value Share by Application (2018-2023)
   Figure 28. Global Medical Isotopes Market Share Forecast by Application (2024-2029)
   Figure 29. North America Medical Isotopes Consumption Value Market Share by Type (2018-2029)
   Figure 30. North America Medical Isotopes Consumption Value Market Share by Application (2018-2029)
   Figure 31. North America Medical Isotopes Consumption Value Market Share by Country (2018-2029)
   Figure 32. United States Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 33. Canada Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 34. Mexico Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 35. Europe Medical Isotopes Consumption Value Market Share by Type (2018-2029)
   Figure 36. Europe Medical Isotopes Consumption Value Market Share by Application (2018-2029)
   Figure 37. Europe Medical Isotopes Consumption Value Market Share by Country (2018-2029)
   Figure 38. Germany Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 39. France Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 40. United Kingdom Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 41. Russia Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 42. Italy Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 43. Asia-Pacific Medical Isotopes Consumption Value Market Share by Type (2018-2029)
   Figure 44. Asia-Pacific Medical Isotopes Consumption Value Market Share by Application (2018-2029)
   Figure 45. Asia-Pacific Medical Isotopes Consumption Value Market Share by Region (2018-2029)
   Figure 46. China Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 47. Japan Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 48. South Korea Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 49. India Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 50. Southeast Asia Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 51. Australia Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 52. South America Medical Isotopes Consumption Value Market Share by Type (2018-2029)
   Figure 53. South America Medical Isotopes Consumption Value Market Share by Application (2018-2029)
   Figure 54. South America Medical Isotopes Consumption Value Market Share by Country (2018-2029)
   Figure 55. Brazil Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 56. Argentina Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 57. Middle East and Africa Medical Isotopes Consumption Value Market Share by Type (2018-2029)
   Figure 58. Middle East and Africa Medical Isotopes Consumption Value Market Share by Application (2018-2029)
   Figure 59. Middle East and Africa Medical Isotopes Consumption Value Market Share by Country (2018-2029)
   Figure 60. Turkey Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 61. Saudi Arabia Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 62. UAE Medical Isotopes Consumption Value (2018-2029) & (USD Million)
   Figure 63. Medical Isotopes Market Drivers
   Figure 64. Medical Isotopes Market Restraints
   Figure 65. Medical Isotopes Market Trends
   Figure 66. Porters Five Forces Analysis
   Figure 67. Manufacturing Cost Structure Analysis of Medical Isotopes in 2022
   Figure 68. Manufacturing Process Analysis of Medical Isotopes
   Figure 69. Medical Isotopes Industrial Chain
   Figure 70. Methodology
   Figure 71. Research Process and Data Source